年龄依赖性免疫应答与免疫耐受的HBV感染小鼠模型
研究通过将Rag1-/-小鼠与HBV-Tg小鼠杂交建立HBVRag1小鼠,分别过继转移成年(8-9周龄)和幼年(3周龄)脾细胞,命名为HBVRag-ReA和HBVRag-ReY小鼠。HBVRag-ReA小鼠出现肝细胞损伤、HBsAg清除及HBsAb和HBcAb产生;HBVRag-ReY小鼠无ALT升高,产生HBcAb和HBsAg,血清定量抗-HBc水平显著高于HBV-Tg小鼠(P < .01,约10倍)。HBVRag-ReY小鼠的年龄相关耐受可被抗生素处理调节,GS-9620可抑制HBsAg产生,HBV疫苗接种可在低HBsAg水平HBVRag-ReY小鼠中诱导持续血清学转换。
要点
- HBVRag-ReA小鼠出现肝细胞损伤、HBsAg清除及HBsAb和HBcAb产生。
- HBVRag-ReY小鼠无ALT升高,产生HBcAb和HBsAg。
- HBVRag-ReY小鼠血清定量抗-HBc水平显著高于HBV-Tg小鼠(P < .01,约10倍)。
核心结论
- 本研究描述了一种具有年龄依赖性免疫和免疫耐受的HBV感染小鼠模型,可能模拟人类慢性HBV感染。
研究设计与样本
- 将Rag1-/-小鼠与HBV-Tg小鼠杂交生成HBVRag1小鼠。
- 过继转移成年(8-9周龄)脾细胞后命名为HBVRag-ReA小鼠。
- 过继转移幼年(3周龄)脾细胞后命名为HBVRag-ReY小鼠。
- 检测与病毒载量和免疫功能相关的生化参数及肝组织学。
- 通过定量乙型肝炎核心抗体测定、过继转移及添加抗生素调节肠道菌群评估HBVRag-ReY小鼠的免疫耐受。
主要发现
- HBVRag-ReA小鼠显示明显肝细胞损伤、HBsAg清除及HBsAb和HBcAb产生。
- HBVRag-ReY小鼠未出现ALT升高,产生HBcAb和HBsAg。
- 淋巴细胞转移30天后,HBVRag-ReA小鼠肝脏CD8+ T细胞和B细胞数量较高,促进HBsAg清除。
- 与HBVRag-ReA小鼠相比,HBVRag-ReY小鼠Th1/Th2细胞因子水平较高。
- HBVRag-ReY小鼠血清定量抗-HBc水平显著高于HBV-Tg小鼠(P < .01,约10倍)。
关键数值与推荐
- HBVRag-ReY小鼠血清定量抗-HBc水平较HBV-Tg小鼠显著升高(P < .01,约10倍)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Viral clearance of human HBV infection largely depends on the age of exposure. Thus, a mouse model with age-dependent immune response and immune-tolerance for HBV infection was established. METHODS: HBVRag1 mice were generated by crossing Rag1-/- mice with HBV-Tg mice. Following adoptive transfer of splenocytes adult (8-9 weeks old) and young (3 weeks old) HBVRag1 mice were named as HBVRag-ReA and HBVRag-ReY mice respectively. The biochemical parameters that were associated with viral load and immune function, as well as the histological evaluation of the liver tissues between the two mouse models were detected. The immune tolerance of HBVRag-ReY mice that were reconstituted at the early stages of life was evaluated by quantitative hepatitis B core antibody assay, adoptive transfer, and modulation of gut microbiota with the addition of antibiotics. RESULTS: HBVRag-ReA mice indicated apparent hepatocytes damage, clearance of HBsAg and production of HBsAb and HBcAb. HBVRag-ReY mice did not develop ALT elevation, and produced HBcAb and HBsAg. A higher number of hepatic CD8+ T and B cells promoted clearance of HBsAg in HBVRag-ReA mice following 30 days of lymphocyte transfer. In contrast to HBVRag-ReA mice, HBVRag-ReY mice exhibited higher levels of Th1/Th2 cytokines. HBVRag-ReY mice exhibited significantly higher (P < .01, approximately 10-fold) serum quantitative anti-HBc levels than HBV-Tg mice, which might be similar to the phase of immune clearance and immune tolerance in human HBV infection. Furthermore, the age-related tolerance in HBVRag-ReY mice that were sensitive to antibiotic treatment was different from that noted in HBV-Tg mice. GS-9620 could inhibit the production of HBsAg, whereas HBV vaccination could induce sustained seroconversion in HBVRag-ReY mice with low levels of HBsAg. CONCLUSIONS: The present study described a mouse model with age-dependent immunity and immune-tolerance for HBV infection in vivo, which may mimic chronic HBV infection in humans.
引用
- Yi X, Yuan Y, Li N, et al. A mouse model with age-dependent immune response and immune-tolerance for HBV infection. Vaccine. 2018. PMID: 29306503. doi:10.1016/j.vaccine.2017.12.071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。